Log in to save to my catalogue

Theaflavin 3, 3′-Digallate Delays Ovarian Aging by Improving Oocyte Quality and Regulating Granulosa...

Theaflavin 3, 3′-Digallate Delays Ovarian Aging by Improving Oocyte Quality and Regulating Granulosa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8674650

Theaflavin 3, 3′-Digallate Delays Ovarian Aging by Improving Oocyte Quality and Regulating Granulosa Cell Function

About this item

Full title

Theaflavin 3, 3′-Digallate Delays Ovarian Aging by Improving Oocyte Quality and Regulating Granulosa Cell Function

Publisher

United States: Hindawi

Journal title

Oxidative medicine and cellular longevity, 2021, Vol.2021 (1), p.7064179-7064179

Language

English

Formats

Publication information

Publisher

United States: Hindawi

More information

Scope and Contents

Contents

Ovarian aging refers to the gradual decline of ovarian function with increasing physiological age, manifested as decreased ovarian reserve, elevated aging-related markers, and reduced oocyte quality. With a declining female fertility and a growing aging population, it is urgent to delay ovarian aging to maintain fertility and improve the life quali...

Alternative Titles

Full title

Theaflavin 3, 3′-Digallate Delays Ovarian Aging by Improving Oocyte Quality and Regulating Granulosa Cell Function

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8674650

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8674650

Other Identifiers

ISSN

1942-0900

E-ISSN

1942-0994

DOI

10.1155/2021/7064179

How to access this item